Towards Healthcare

Optical Coherence Tomography Top Leaders, Innovation and Product Evolution

Date : 22 October 2025

Leaders in the Optical Coherence Tomography Market and Innovation

Optical Coherence Tomography Market Companies

  • Carl Zeiss Meditec
  • Heidelberg Engineering
  • Topcon Healthcare
  • Canon Medical Systems / Canon (Tomey & Canon ophthalmic units)
  • NIDEK
  • Optovue
  • Haag-Streit
  • Leica Microsystems / Leica Ophthalmic
  • Thorlabs
  • Santec
  • Lumedica
  • Wasatch Photonics / OCT component suppliers
  • Abbott
  • Terumo
  • Boston Scientific
  •  Philips

Market Forecast

The global optical coherence tomography market size was estimated at US$ 2.26 billion in 2024, projected to increase to US$ 2.62 billion in 2025 and reach US$ 10 billion by 2034, showing a healthy CAGR of 15.97% across the forecast years.

Adoption of Inorganic Strategies

  • In May 2025, Nokia and Celesta Capital revealed that Astranu, a business has formally separated from Nokia as part of a partnership to speed up the commercialization of cutting-edge technologies, revolutionizing hearing care through next-generation imaging technology. This was the first project under the partnership between Nokia and Celesta Capital using cutting-edge, non-invasive, high-resolution 3D imaging, Astranu uses proprietary integrated Optical Coherence Tomography (CT) technology created by Nokia Bell Labs with the goal of revolutionizing ear diagnostic care.

Advancements in Imaging Technologies

Integration of AI and advancement in the tomography has driven the market. AI algorithms are increasingly being incorporated into OCT systems to enhance diagnostic accuracy, automate image analysis, and assist in disease detection, particularly in ophthalmology.  

  • In March 2025, Moorfields Eye Hospital NHS Foundation Trust and U.S. biotechnology company Insitro have partnered to increase their efforts in neurodegenerative diseases. A joint press release states that Insitro will collaborate with the INSIGHT Health Data Research Hub at Moorfields Eye Hospital in London to leverage its machine learning-enabled drug discovery and development resources. The goal of the partner program is to assist in the creation of a foundational AI model that will direct accurate patient segmentation and offer additional details on biomarkers for a range of diseases.

Value Chain Analysis – Optical Coherence Tomography Market

Research & Development (R&D)

Development of advanced OCT technologies (e.g., Spectral-Domain OCT, Swept-Source OCT, OCT Angiography), AI-based image analysis, and miniaturized portable devices. Universities, research institutes, and medical device companies focus on innovation and prototyping.

Companies: Topcon Corporation (Japan), Carl Zeiss Meditec (Germany), Canon Medical Systems (Japan), Heidelberg Engineering (Germany).

Institutions: Massachusetts Institute of Technology (MIT), University of Tsukuba (Japan), Stanford University (USA).

Distribution to Hospitals, Pharmacies

Large-scale production of optical coherence tomography hardware, software, and consumables; quality control; distribution via direct sales, local distributors, and global channels. Companies also partner with regional suppliers to expand presence in emerging markets.

Manufacturers: Nidek (Japan), Optovue (USA, now part of Zeiss), Abbott (USA – intravascular OCT), Thorlabs (USA).

Distributors: Henry Schein (USA), local medical equipment distributors in China & India.

Patient Support and Services

Deployment of OCT systems in hospitals, ophthalmic clinics, cardiology labs, dermatology centers, and research institutes. Includes physician training, patient support, and integration with AI diagnostic software for improved outcomes.

Healthcare Providers: Mayo Clinic (USA), Aravind Eye Care (India), Seoul National University Hospital (South Korea), Peking Union Medical College Hospital (China).

Patient Support Programs: American Academy of Ophthalmology (AAO), International Agency for the Prevention of Blindness (IAPB).

Latest Announcement by Industry Leaders

In July 2024, the U.S. Food and Drug Administration announced the approval of the Heidelberg Engineering company’s OCTA (Spectralis CT angiography) module with SHIFT technology. This technology cuts acquisition time by 50%. The 125kHz preset OCTA speed is intended to improve clinical efficiencies, expedite workflow, and preserve image quality from Heidelberg.

Recent Developments in the Optical Coherence Tomography Market

  • In May 2025, Optos announced the release of MonacoPro, a spectral domain retinal imaging solution and next-generation ultra-widefield (UWF) SLO. Building on Monaco's heritage, Optos stated that MonacoPro offers features intended to improve diagnostic accuracy and expedite workflow for eye care providers globally.
  • In May 2025, Topcon Healthcare, Inc. declared the debut of an ocular data-as-a-service platform that emphasizes advancements and research in the Institute of Digital Health (IDHea) is a digital health organization.

Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com